About Cellplus Bio
An Innovative Company Focused on Chemically Defined (CD) Cell Culture Media
Cellplus Bio provides cell culture solutions with consistent long-term quality and no batch-to-batch variation for antibody therapeutics, vaccines, cell and gene therapy (CGT), and other applications. We help customers unlock the full potential of different cell types and accelerate the journey from R&D to commercialization. Established in February 2021 in Suzhou New District, Cellplus Bio is a Sino-European joint venture. Our R&D and manufacturing facilities cover over 8,000 square meters, and our products serve all major cell culture systems, including CHO, HEK293, Vero, BHK, Sf9, and Hi5. Two industrial-scale production lines in China, validated in large-scale manufacturing, ensure a continuous supply of dry powder media. We can produce approximately 100,000 liters of media (2 tonnes of dry powder) in a single batch in as little as 48 hours, or 200,000 liters within 72 hours......
20 years
Media R&D & Production
8~12 ×10,000 L
Batch Capacity
1000+ tonnes
Dry Powder Produced
8000m²
GMP-Standard Facility